Bill > SCR38

This concurrent resolution addresses the critical issue of atherosclerotic cardiovascular disease (ASCVD), a serious health condition characterized by cholesterol buildup in arteries that increases the risk of heart-related events. The resolution urges the Governor to direct state departments and agencies to take several actions to reduce ASCVD fatalities, including reviewing and updating existing policies, exploring collaboration with federal and national agencies to establish comprehensive cardiovascular health screening programs, and directing the Department of Health to update the state's cardiovascular plan to improve patient care, screening, treatment, and monitoring. The resolution highlights the significant impact of ASCVD in the United States, noting that it is the leading cause of death, affects approximately 21 million Americans, and has substantial economic implications, with total costs projected to reach $1.1 trillion by 2035. In New Jersey specifically, 566,100 adults have been diagnosed with ASCVD-related conditions, and the state spends an estimated $3.39 billion annually on related medical expenses. The resolution aims to encourage proactive measures to address this widespread health challenge by promoting better prevention, screening, and treatment strategies.

Health and Social Services

https://www.njleg.state.nj.us/bill-search/2024/SCR38